A first-in-human study shows that gene therapy improved vision in young children with severe AIPL1-related retinal dystrophy, preserving retinal structure and enhancing visual function.
🔗 www.thelancet.com/journals/lan...
#GeneTherapy #SciComm 🧪
A first-in-human study shows that gene therapy improved vision in young children with severe AIPL1-related retinal dystrophy, preserving retinal structure and enhancing visual function.
🔗 www.thelancet.com/journals/lan...
#GeneTherapy #SciComm 🧪
"Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study"
www.thelancet.com/journals/lan...
"Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study"
www.thelancet.com/journals/lan...
🔗 tinyurl.com/bdeezck3
🔗 tinyurl.com/bdeezck3
From The Lancet: Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study
www.thelancet.com/journals/lan...
#ophthalmology #genetherapy
@
From The Lancet: Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study
www.thelancet.com/journals/lan...
#ophthalmology #genetherapy
@
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study. 🧪👁️🧬 #medsky
www.thelancet.com/journals/lan...
Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study. 🧪👁️🧬 #medsky
www.thelancet.com/journals/lan...
A terapia consiste em uma injeção de cópias saudáveis do gene AIPL1 na retina. Essas cópias são transportadas em um vírus inofensivo.
A terapia consiste em uma injeção de cópias saudáveis do gene AIPL1 na retina. Essas cópias são transportadas em um vírus inofensivo.
In 4 children (1-2.8 y) with AIPL1 severe retinal dystrophy, subretinal injection of rAAV vector carrying the human AIPL1 gene led from legal blindness to significant gains in visual acuity over 3.5 years
🔗 www.thelancet.com/journals/lan...
In 4 children (1-2.8 y) with AIPL1 severe retinal dystrophy, subretinal injection of rAAV vector carrying the human AIPL1 gene led from legal blindness to significant gains in visual acuity over 3.5 years
🔗 www.thelancet.com/journals/lan...
ow.ly/cVnA50Vq3nq
@isscr.org
ow.ly/cVnA50Vq3nq
@isscr.org
www.thelancet.com/journals/lan...
#RetinalDystrophy #AIPL1 #GeneTherapy #MedSky
www.thelancet.com/journals/lan...
#RetinalDystrophy #AIPL1 #GeneTherapy #MedSky
https://nplus1.ru/news/2025/02/21/gene-therapy-aipl1
#главноезанеделю
https://nplus1.ru/news/2025/02/21/gene-therapy-aipl1
#главноезанеделю
AIPL1-associated retinal dystrophy - Medical Xpress: Gene therapy can improve vision in… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #competitivemarketing #pharmaceutical #healthcare
AIPL1-associated retinal dystrophy - Medical Xpress: Gene therapy can improve vision in… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #competitivemarketing #pharmaceutical #healthcare
medicalxpress.com/news/2025-02...
www.thelancet.com/journals/lan...
medicalxpress.com/news/2025-02...
www.thelancet.com/journals/lan...
#GeneTherapy #MedicalBreakthrough #ChildhoodBlindness #LCA #VisionRestoration
#GeneTherapy #MedicalBreakthrough #ChildhoodBlindness #LCA #VisionRestoration